PRESS RELEASE 2016

PARSIPPANY, N.J., Nov. 14, 2016 /PRNewswire/ -- Ferring Pharmaceuticals Inc. will continue its leadership role as one of four national sponsors for the more than 100 Arthritis Foundation Jingle Bell Run events taking place in cities across the country. Through this sponsorship, Ferring Pharmaceut...

PARSIPPANY, N.J., September 14, 2016 – Ferring Pharmaceuticals was recognized as the most Adoption-Friendly Workplace in the United States by the Dave Thomas Foundation for Adoption, America’s only nonprofit public charity dedicated to finding homes for children in foster care.

Ferring Pharmaceuticals announced today that it has signed an agreement with Seikagaku Corporation granting Ferring the exclusive worldwide rights (excluding Japan) to SI-6603 (condoliase), a chemonucleolytic product in Phase III development for the treatment of radicular leg pain (e.g. sciatica)...

Have you ever heard people talk about how having a baby later in life is easy, so long as you’re healthy and in good shape? Or, that issues with fertility are usually the woman’s fault? These are just a few of the many myths about fertility and why Ferring Pharmaceuticals has launched Fertility F...

Ferring Pharmaceuticals Inc. today announced Katie and Jake Barber of Waterford, Mich. as the winners of its annual Heart to Heart Video Contest. The Barber family received the highest number of votes in the contest's history. For more than a decade, the company has been providing parents who str...

PARSIPPANY, N.J., March 1, 2016 – Ferring Pharmaceuticals today announced that Aaron Graff has been appointed Chief Executive Officer of Ferring Holding Inc. In this role Mr. Graff assumes direct responsibility for all Ferring US activities including commercial operations (Ferring Pharmaceuticals...